Epilepsy in Muenke Syndrome: FGFR3-Related Craniosynostosis-Reference-Cited by-同舟云学术

Epilepsy in Muenke Syndrome: FGFR3-Related Craniosynostosis

Published:2012-11 Issue:5 Volume:47 Page:355-361
ISSN:0887-8994
Container-title:Pediatric Neurology
language:en
Short-container-title:Pediatric Neurology

Author:

Agochukwu Nneamaka B.,Solomon Benjamin D.,Gropman Andrea L.,Muenke Maximilian

Funder

Division of Intramural Research of the National Human Genome Research Institute at the National Institutes of Health and the Department of Health and Human Services

Publisher

Elsevier BV

Subject

Clinical Neurology,Developmental Neuroscience,Neurology,Pediatrics, Perinatology, and Child Health

Reference30 articles.

1. Prevalence and complications of single gene and chromosomal disorders in craniosynostosis;Wilkie;Pediatrics,2010

2. A unique point mutation in the fibroblast growth factor receptor 3 gene (FGFR3) defines a new craniosynostosis syndrome;Muenke;Am J Hum Genet,1997

3. Identical mutations in three different fibroblast growth factor receptor genes in autosomal dominant craniosynostosis syndromes;Bellus;Nat Genet,1996

4. Nonpenetrance in FGFR3-associated coronal synostosis syndrome;Robin;Am J Med Genet,1998

5. Epilepsy;Chang;N Engl J Med,2003

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Genetic Testing in Craniofacial Care: Development of Algorithms for Testing Patients with Orofacial Clefting, Branchial Arch Anomalies, and Craniosynostosis;The Cleft Palate Craniofacial Journal;2024-08-18

2. Are Patients with Syndromic Craniosynostosis at Greater Risk for Epilepsy than Patients with Nonsyndromic Craniosynostosis?;World Neurosurgery;2024-01

3. Infigratinib, a selective FGFR1‐3 tyrosine kinase inhibitor, alters dentoalveolar development at high doses;Developmental Dynamics;2023-07-12

4. What Are the Risk Factors for Epilepsy Among Patients With Craniosynostosis?;Journal of Oral and Maxillofacial Surgery;2022-07

5. Hypochondroplasia and temporal lobe epilepsy – A series of 4 cases;Epilepsy & Behavior;2022-01